Back to Search
Start Over
A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
- Source :
- Journal of Clinical Oncology. 36:1017-1017
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- 1017Background: Overall response rates of 5-7% have been reported with checkpoint inhibitor monotherapy in PD-L1-unselected mTNBC as second line or subsequent therapy. RT is frequently used to enha...
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Immune checkpoint inhibitors
Pembrolizumab
Radiation therapy
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Overall response rate
Second line
030220 oncology & carcinogenesis
Internal medicine
medicine
business
Triple-negative breast cancer
Single Arm Study
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........bac1f3e91d2bbfe8c4713ed5126d40aa
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.1017